“These estimates are reassuring,” says Brendan Flannery, PhD, the CDC’s investigator for the US Flu Vaccine Effectiveness Network.
February 20, 2020
February 3, 2020
An adjuvanted influenza A H5N1 monovalent vaccine (Audenz) has been approved by the US Food and Drug Administration (FDA). The approval was granted to Seqirus.
January 23, 2020
Testing on human subjects could begin in 3 months.